Case studies in cost effectiveness of molecular diagnostics for infectious diseases: pulmonary tuberculosis, enteroviral meningitis, and BK virus nephropathy.
Pathogen genome amplification is used to detect and identify microorganisms, assess response to therapy, and detect mutations associated with drug resistance. Nucleic acid amplification tests have been shown to be superior to conventional culture-based testing methods in many circumstances. However, the enthusiasm for the technology in clinical laboratories may be decreased by the practical considerations of cost, complexity of the technology, and lack of US Food and Drug Administration-approved tests. The impact of nucleic acid amplification tests on the diagnosis and management of patients with tuberculosis, enteroviral meningitis, and BK virus transplant nephropathy will be examined, with an emphasis on the potential for health care cost savings.
Nolte
Frederick S
FS
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. fnolte@emory.edu
D001739:BK Virus / Q000302:isolation & purification; D003362:Cost-Benefit Analysis; D004769:Enterovirus Infections / Q000175:diagnosis* / Q000191:economics / Q000821:virology; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis* / Q000191:economics / Q000821:virology; D008587:Meningitis, Viral / Q000175:diagnosis* / Q000191:economics / Q000821:virology; D021141:Nucleic Acid Amplification Techniques / Q000191:economics*; D027601:Polyomavirus Infections / Q000175:diagnosis* / Q000191:economics; D012680:Sensitivity and Specificity; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000191:economics; D014412:Tumor Virus Infections / Q000175:diagnosis* / Q000191:economics